Eventide Asset Management, Llc

Source: SEC Form 13F · as of Mar 2026

Eventide Asset Management, Llc holds 59 biotech & pharma companies tracked by BioSniper, totaling $1.90B in value as of Mar 2026 (SEC Form 13F).

Companies held

59

Total value held

$1.90B

CompanySharesValue
GHGuardant Health Inc.2,362,379$218.1M
MIRMMirum Pharmaceuticals, Inc.1,408,871$130.1M
SRRKScholar Rock Holding Corp2,197,385$107.9M
ARGXARGENX SE125,657$91.7M
INSMINSMED Inc546,310$89.3M
AXSMAxsome Therapeutics, Inc.519,558$87.8M
PCVXVaxcyte, Inc.1,374,292$79.8M
RPRXRoyalty Pharma plc1,312,534$62.6M
BBNXBeta Bionics Inc.5,945,488$59.6M
BLTEBELITE BIO, INC357,650$57.0M
KYMRKymera Therapeutics, Inc.626,925$52.2M
COLLCOLLEGIUM PHARMACEUTICAL, INC1,424,282$47.1M
APGEApogee Therapeutics, Inc.557,423$46.9M
IONSIONIS PHARMACEUTICALS INC575,000$43.2M
ABVXAbivax SA320,576$35.7M
CLDXCelldex Therapeutics, Inc.1,037,000$32.9M
BBIOBridgeBio Pharma, Inc.437,130$32.5M
CYTKCYTOKINETICS INC479,098$31.6M
TRVITrevi Therapeutics, Inc.2,622,306$31.3M
PVLAPALVELLA THERAPEUTICS, INC.233,248$29.0M
KMTSKestra Medical Technologies Ltd.1,445,864$28.8M
EVMNEvommune, Inc.1,209,129$27.8M
MBXMBX Biosciences, Inc.890,000$26.6M
CNTACentessa Pharmaceuticals plc668,142$26.5M
SIONSionna Therapeutics, Inc.645,530$25.9M
RVMDREVOLUTION MEDICINES, INC.261,425$25.4M
IRONDisc Medicine, Inc.395,572$25.3M
CGONCG Oncology, Inc.369,985$25.0M
IMMXImmix Biopharma, Inc.2,549,019$23.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.370,000$23.2M
OVIDOvid Therapeutics Inc.9,916,911$22.0M
ADCTADC Therapeutics SA5,701,655$21.4M
AMLXAmylyx Pharmaceuticals, Inc.1,513,958$21.0M
NRIXNurix Therapeutics, Inc.1,297,893$20.1M
DNTHDianthus Therapeutics, Inc. /DE/225,261$18.9M
STROSUTRO BIOPHARMA, INC.715,307$17.8M
UTHRUNITED THERAPEUTICS Corp28,552$16.9M
DFTXDefinium Therapeutics Inc.686,162$13.0M
PRAXPraxis Precision Medicines, Inc.38,640$12.4M
ORICOric Pharmaceuticals, Inc.953,451$12.1M
IVVDInvivyd, Inc.9,071,995$11.8M
OCSOculis Holding AG430,000$11.4M
AMGNAMGEN INC28,647$10.0M
DRUGBRIGHT MINDS BIOSCIENCES INC.130,013$9.5M
CSTLCastle Biosciences Inc.386,425$9.5M
AKTSAktis Oncology Inc.507,000$9.1M
CRVSCorvus Pharmaceuticals, Inc.550,000$8.0M
HELPCYBIN INC.1,410,815$6.8M
RLMDRELMADA THERAPEUTICS, INC.842,106$5.9M
EWTXEdgewise Therapeutics, Inc.149,863$4.7M
BBOTBridgeBio Oncology Therapeutics, Inc.541,181$4.7M
LLYELI LILLY & Co5,121$4.6M
CTMXCytomX Therapeutics, Inc.900,000$4.2M
ZTSZoetis Inc.7,048$820K
IDXXIDEXX LABORATORIES INC /DE782$436K
ALNYALNYLAM PHARMACEUTICALS, INC.1,111$351K
PTGXProtagonist Therapeutics, Inc2,795$279K
DGXQuest Diagnostics Incorporated1,112$219K
GERNGERON CORP25,657$36K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.